Skip to main content
Log in

Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ulrich CM, Robien K, McLeod HL (2003) Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer 3:912–920

    Article  PubMed  CAS  Google Scholar 

  2. Lecomte T, Ferraz JM, Zinzindohoue F et al (2004) Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res 10:5880–5888

    Article  PubMed  CAS  Google Scholar 

  3. Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M (2002) Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100:3832–3834

    Article  PubMed  Google Scholar 

  4. National Cancer Institute (1998) Common toxicity criteria, version 2.0. National Cancer Institute, Bethesda, MD

    Google Scholar 

  5. Yi P, Pogribny IP, James SJ (2002) Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett 181:209–213

    Article  PubMed  CAS  Google Scholar 

  6. Hongeng S, Sasanakul W, Chuansumrit A, Pakakasama S, Chattananon A, Hathirat P (2000) Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Med Pediatr Oncol 35:410–414

    Article  CAS  Google Scholar 

  7. van Ede AE, Laan RF, Blom HJ et al (2001) The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 44:525–530

    Google Scholar 

  8. Shimasaki N, Mori T, Samejima H et al (2006) Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 28:64–68

    Article  PubMed  CAS  Google Scholar 

  9. Aplenc R, Thompson J, Han P et al (2005) Methyltetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65:2482–2487

    Article  PubMed  CAS  Google Scholar 

  10. Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63:1227–1231

    Article  PubMed  CAS  Google Scholar 

  11. Herrlinger KR, Cummings JRF, Barnardo MC, Schwab M, Ahmad T, Jewell DP (2005) The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenetics Genomics 15:705–711

    Article  CAS  Google Scholar 

  12. Cheok MH, Lugthart S, Evans WE (2006) Pharmacogenomics of acute leukemia. Ann Rev Pharmacol Toxicol 46:317–353

    Article  CAS  Google Scholar 

  13. Stanulla M, Schaeffeler E, Flohr T et al (2005) Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 23:1485–1489

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by Ramathibodi Research Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samart Pakakasama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pakakasama, S., Kanchanakamhaeng, K., Kajanachumpol, S. et al. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia. Ann Hematol 86, 609–611 (2007). https://doi.org/10.1007/s00277-007-0274-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0274-x

Keywords

Navigation